If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
Myelodysplastic Syndromes Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences
Mutation Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
Hematologic Neoplasms Medicine & Life Sciences
Second Primary Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2018

  • 345 Citations
  • 10 h-Index
  • 29 Article
  • 4 Letter
  • 4 Review article
  • 3 Comment/debate

A 68-Year-Old Man With Chronic Myelogenous Leukemia and a Large Unilateral Pleural Effusion

Alter, A., Chaisson, N., Mukherjee, S. & Gildea, T., Feb 1 2018, In : CHEST. 153, 2, p. 339-348 10 p.

Research output: Contribution to journalArticle

tamsulosin
Pleural Effusion
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
BCG Vaccine
Middle East
3 Citations

Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies

Statler, A., Othus, M., Erba, H. P., Chauncey, T. R., Radich, J. P., Coutre, S., Advani, A. S., Nand, S., Ravandi, F., Mukherjee, S. & Sekeres, M., Jun 21 2018, In : Blood. 131, 25, p. 2782-2788 7 p.

Research output: Contribution to journalArticle

Oncology
Leukemia
Survival
Documentation
Clinical Trials
1 Citations

Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms

Balasubramanian, S. K., Aly, M., Nagata, Y., Bat, T., Przychodzen, B. P., Hirsch, C. M., Adema, V., Visconte, V., Kuzmanovic, T., Radivoyevitch, T., Nazha, A., Mukherjee, S., Sekeres, M. & Maciejewski, J. P., Feb 1 2018, In : Leukemia. 32, 2, p. 550-553 4 p.

Research output: Contribution to journalLetter

Mutation
Neoplasms
4 Citations

Idh1/2 mutations sensitize acute myeloid leukemia to parp inhibition and this is reversed by idh1/2-mutant inhibitors

Molenaar, R. J., Radivoyevitch, T., Nagata, Y., Khurshed, M., Przychodzen, B., Makishima, H., Xu, M., Bleeker, F. E., Wilmink, J. W., Carraway, H. E., Mukherjee, S., Sekeres, M., van Noorden, C. J. F. & Maciejewski, J. P., Apr 1 2018, In : Clinical Cancer Research. 24, 7, p. 1705-1715 11 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Daunorubicin
Mutation
Myeloid Cells
DNA Damage

Initiation of venovenous extracorporeal membrane oxygenation in a patient receiving induction chemotherapy for acute myelogenous leukemia

Avasarala, S. K., Qureshi, M. R., Waldron, M., Mukherjee, S. & Reddy, A. J., Jan 1 2018, (Accepted/In press) In : Journal of Oncology Pharmacy Practice.

Research output: Contribution to journalArticle

Extracorporeal Membrane Oxygenation
Induction Chemotherapy
Acute Myeloid Leukemia
Hematologic Neoplasms
Patient Admission